Right before the diagnosis, Alley Stanley barely slept or ate, consumed by research and doubt, she told Newsweek.
They say kindness is its own reward, and for South Elgin resident David Luplow Jr. that’s no doubt true. But it’s also nice to be recognized for an act of kindness, especially when it’s with an award ...
Lifyorli combo approved for ovarian cancer; mixed results from Lyme disease vaccine trial; treatment approved for rare Hunter ...
In today’s Pharma Pulse, experts warn of zero-prefix collision risks in the NDC-12 transition, and the FDA grants accelerated ...
Health and Me on MSN
US FDA approves drug to treat rare childhood syndrome
The drug Avlayah, developed by pharma company Denali Therapeutics, addresses the neurologic complications of Hunter Syndrome, ...
The FDA granted accelerated approval to tividenofusp alfa (Avlayah) for the treatment of mucopolysaccharidosis type II (MPS ...
FDA accelerated approval of tividenofusp alfa-eknm offers a new treatment for neurologic manifestations in patients with Hunter syndrome.
FDA OKs 1st Hunter syndrome therapy Avlayah to treat neurologic symptoms in pediatric patients with mucopolysaccharidosis Type 2.
The approval of Denali’s Hunter syndrome treatment, Avlayah, comes after a series of drug rejections and delays that had led ...
Last month, the FDA rejected a Hunter syndrome gene therapy from Regenxbio over a lack of clinical data. Denali Therapeutics' drug is a form of enzyme replacement therapy — not a gene therapy — that ...
Avlayah is the first Hunter syndrome therapy approved to address the condition’s neurologic complications, according to Tracy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results